A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

By sjmartinez • March 7, 2025

Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Feb 19;7(1):vdaf022. doi: 10.1093/noajnl/vdaf022. PMID: 40051661; PMCID: PMC11883343.

Tags: Cardiology/Epi, EGFR, FDG PET, Glioblastoma, imaging biomarker, molecular imaging, Osimertinib, Publications

In-Depth optimization and characterization of prostatic and penile vessel imaging with Ferumoxytol-enhanced magnetic resonance imaging

Fang D, McWIlliams J, Wang C, Maziero D, Iwamoto KS, Kishan AU, Finn JP, Zhong X, Ruan D. In-Depth optimization and characterization of prostatic and[...]

Attenuation of advanced atherosclerosis and aortic aneurysm in hph-1/apoE DKO mice by folic acid and DHFR overexpression

Zhang Y, Siu KL, Huang K, Huang Y, Cai H. Attenuation of advanced atherosclerosis and aortic aneurysm in hph-1/apoE DKO mice by folic acid and[...]

Impinged and Disrupted Left Bundle Branch by a Transcatheter Self-Expandable Aortic Valve

Miyazaki K, Olivas JA, Miyazaki Y, Sato T, Rimmer M, Moussa ID, Fishbein MC, Shivkumar K, Mori S. Impinged and Disrupted Left Bundle Branch by[...]